Category

Vascular BioSciences Presented Results of CAR Peptide Targeted Augmentation of Chronic Prostanoid Treatment in PAH at the ATS Meeting in Dallas, Texas New data on beneficial effects of co-administration of CAR peptide with treprostinil in experimental pulmonary hypertension GOLETA — V

Vascular BioSciences Awarded $2 Million Phase II STTR Grant From NHLBI to Develop CAR Peptide as a Targeted Therapy for Pulmonary Hypertension Grant awarded in partnership with Brigham and Women’s Hospital, Harvard Medical School Durham, North Carolina – Vascular BioSciences (VB